Founded in 1979 by John Abele and Pete Nicholas, Boston Scientific Corporation is a leading global medical technology company focused on minimally invasive devices and therapies that improve patient care across a broad range of interventional specialties. Headquartered in Marlborough, Massachusetts, the company has built a strong international presence through sustained innovation across interventional cardiology, cardiac rhythm management, electrophysiology, endoscopy, neuromodulation, peripheral interventions, and urology. As of 2025, Boston Scientific employed approximately 59,000 people worldwide, maintained commercial representation in 127 countries, and reported net sales of $20.0 billion, reflecting the scale of a business dedicated to advancing science for life.
Updated 2026-03-19